Angina
Data on angina discussed by researchers at Charles University
Published in Blood Weekly, August 7th, 2008
According to recent research from Prague, Czech Republic, " To compare two different clopidogrel regimens on the outcomes of patients undergoing elective coronary angiography (CAG)+/- ad hoc percutaneous coronary intervention (PCI). Methods and results Open-trial randomized 1028 patients with stable angina to group A ('non-selective'-clopidogrel 600 mg > 6 h before CAG; n = 513) or group B ('selective'-clopidogrel 600 mg in the cath-lab after CAG, only in case of PCI; n = 515)."
"Combined primary endpoint was death/periprocedural myocardial infarction (MI)/stroke/re-intervention within 7 days. Secondary endpoints were troponin elevation and bleeding complications....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-08-07)
More Articles from Blood Weekly
- Alcoholism
Water-diffusion technology identifies brain regions damaged by prenatal alcohol exposure - American Society of Nephrology
'Statins' linked to improved survival in kidney transplant recipients - BMJ-British Medical Journal
No justification for denying obese patients knee replacements - Institute for Research in Biomedicine IRB Barcelona
Discovery of a mechanism that regulates cell movement - University Hospital Heidelberg
Male kidneys for men only? - University of California - San Diego
Discovery of a new signaling mechanism may lead to novel anti-inflammatory therapy - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
